Madrigal Pharmaceuticals Inc (MDGL NASDAQ) stock market data APIs
$325.4528
-25.34(-7.2%)
as of March 14, 2025
Madrigal Pharmaceuticals Inc Financial Data Overview
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. The company offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.
Prev. Close
350.7968
Open
325.4528
High
350.7968
Low
325.7286
52 wk Range
189-377.46
Market Cap
7 692 M
Shares Outstanding
22 080 K
Revenue
180 M
EPS
-2.71
Beta
-0.412
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Madrigal Pharmaceuticals Inc data using free add-ons & libraries
Get Madrigal Pharmaceuticals Inc Fundamental Data
Madrigal Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 180 M
- EBITDA: -496 779 008
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-02-26
- EPS/Forecast: -4.1246
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Madrigal Pharmaceuticals Inc News
New
Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors
Fred Craves, Ph.D. to retire from Madrigal’s Board of Directors in July 2025 CONSHOHOCKEN, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutica...
Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors
Madrigal Pharmaceuticals, Inc. Fred Craves, Ph.D. to retire from Madrigal’s Board of Directors in July 2025 CONSHOHOCKEN, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NA...
Goldman Sachs Says It’s Time to Pull the Trigger on Healthcare Stocks — Here Are 2 Names to Pounce on Now
The markets have been volatile recently as economic uncertainty and tariff threats have rattled investors. Yet, despite the concerns, Goldman Sachs’ chief US equity strategist David Kostin sees reas...
Madrigal Pharmaceuticals price target raised to $239 from $154 at BofA
https://www.tipranks.com/news/the-fly/madrigal-pharmaceuticals-price-target-raised-to-239-from-154-at-bofa BofA raised the firm’s price target on Madrigal Pharmaceuticals (MDGL) to $239 from $154 a...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
